REFERENCES
1.D’Osualdo A, Picco P, Caroli F, Gattorno M, Giacchino R, Fortini P, et al. MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever. European journal of human genetics. 2005;13(3):314-20.
2.Santos JA, Aróstegui JI, Brito MJ, Neves C, Conde M. Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype. Gene. 2014;542(2):217-20.
3.Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S. Hyper-IgD syndrome with novel mutation in a Japanese girl. Modern rheumatology. 2009;19:96-9.
4.Golpour M, Ghaffari J. Hyperimmunoglobulin-D Syndrome in Children: A Review Article. Journal of Pediatrics Review. 2016;4(1):0-.
5.Aygun D, Sahin S, Cokugras H, Kasapcopur O. Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent. BMJ Case Rep. 2016;2016.
6.Tsitsami E, Papadopoulou C, Speletas M. A case of hyperimmunoglobulinemia d syndrome successfully treated with canakinumab. Case Reports in Rheumatology. 2013;2013.
7.Celiksoy MH, Berdeli A, Comba A, Çaltepe G, Yıldıran A. Severe hyper IgD syndrome associated with heterozygote S52N mevalonate kinase mutation. Asthma Allergy Immunology. 2022;15(2):111-4.
8.Houten S, Frenkel J, Waterham H. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cellular and Molecular Life Sciences CMLS. 2003;60:1118-34.
9.Petryna O, Purat N. Mevalonate Kinase Deficiency (MKD)/Hyperimmunoglobulin D Syndrome (HIDS). Auto-Inflammatory Syndromes: Pathophysiology, Diagnosis, and Management. 2019:19-27.
10.Saulsbury FT. Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) in a child with normal serum IgD, but increased serum IgA concentration. The Journal of pediatrics. 2003;143(1):127-9.
11.Petryna O, Purat N. Mevalonate Kinase Deficiency (MKD)/Hyperimmunoglobulin D Syndrome (HIDS). In: Efthimiou P, editor. Auto-Inflammatory Syndromes: Pathophysiology, Diagnosis, and Management. Cham: Springer International Publishing; 2019. p. 19-27.
12.Picco P, Gattorno M, Di Rocco M, Buoncompagni A. Non-steroidal anti-inflammatory drugs in the treatment of hyper-IgD syndrome. Annals of the Rheumatic Diseases. 2001;60(9):904-.
13.Guillem P, Mintoff D, Kabbani M, Cogan E, Vlaeminck-Guillem V, Duquesne A, et al. Case report: comorbid hyper-IgD syndrome and hidradenitis suppurativa–a new syndromic form of HS? A report of two cases. Frontiers in immunology. 2022;13:883811.
14.Drenth JP, Van Der Meer JW. Hereditary periodic fever. New England journal of medicine. 2001;345(24):1748-57.
15.Church LD, Churchman SM, Hawkins PN, McDermott MF, editors. Hereditary auto-inflammatory disorders and biologics. Springer seminars in immunopathology; 2006: Springer.
16.Yoshimura K, Wakiguchi H. Hyperimmunoglobulinemia D syndrome successfully treated with a corticosteroid. Pediatrics international. 2002;44(3):326-7.
17.Tsitsami E, Papadopoulou C, Speletas M. A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab. Case Reports in Rheumatology. 2013;2013:795027.
18.Aygun D, Sahin S, Cokugras H, Kasapcopur O. Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent. Case Reports. 2016;2016:bcr2016214941.
19.Omoyinmi E, Rowczenio D, Sebire N, Brogan PA, Eleftheriou D. Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report. Pediatric Rheumatology. 2021;19:1-4.
20.Boursier G, Rittore C, Milhavet F, Cuisset L, Touitou I. Mevalonate kinase-associated diseases: hunting for phenotype–genotype correlation. Journal of Clinical Medicine. 2021 Apr 7;10(8):1552.
21. Jeyaratnam J, Ter Haar NM, de Sain-van der Velden MG, Waterham HR, van Gijn ME, Frenkel J. Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency (MKD). JIMD Reports, Volume 27. 2016:33-8.
22.Jain A, Misra DP, Sharma A, Wakhlu A, Agarwal V, Negi VS. Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes. Rheumatology international. 2018;38(1):13-24.
23. Bodar EJ, Kuijk LM, Drenth JP, Van Der Meer JW, Simon A, Frenkel J. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Annals of the Rheumatic Diseases. 2011 Dec 1;70(12):2155-8.
24. Kostjukovits S, Kalliokoski L, Antila K, Korppi M. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. European journal of pediatrics. 2015 Jun;174:707-14.